New product set to push RSV market to $5.39B by 2028 - The Pharma Letter
New product set to push RSV market to $5.39B by 2028 The Pharma Letter
New research indicates that the respiratory syncytial virus (RSV) market is expected to grow from $418.6 million in 2018 to $5.39 billion by 2028 across the ...
Comments
Post a Comment